Literature DB >> 2645742

Management of metastatic cancer to the liver.

P H Sugarbaker1, N Kemeny.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2645742

Source DB:  PubMed          Journal:  Adv Surg        ISSN： 0065-3411


× No keyword cloud information.
  7 in total

1.  Improving survival after large bowel cancer.

Authors:  T G Allen-Mersh
Journal:  BMJ       Date:  1991-09-14

Review 2.  Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis.

Authors:  G Scott Gazelle; M G Myriam Hunink; Karen M Kuntz; Pamela M McMahon; Elkan F Halpern; Molly Beinfeld; Jessica S Lester; Kenneth K Tanabe; Milton C Weinstein
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

Review 3.  [MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].

Authors:  A Ba-Ssalamah; B Happel; J Kettenbach; A Dirisamer; F Wrba; F Längle; W Schima
Journal:  Radiologe       Date:  2004-12       Impact factor: 0.635

Review 4.  Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.

Authors:  Ahmed Ba-Ssalamah; Martin Uffmann; Sanjai Saini; Nina Bastati; Christian Herold; Wolfgang Schima
Journal:  Eur Radiol       Date:  2008-09-23       Impact factor: 5.315

5.  Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors.

Authors:  B Böhm; M Voth; J Geoghegan; H Hellfritzsch; A Petrovich; J Scheele; D Gottschild
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-06       Impact factor: 4.553

6.  Does CTAP prior to hepatic resection improve patient survival rates?

Authors:  L S Langmo; A P Dagher; W B Mehard; W C Small; J P Heiken; E K Fishman; M E Bernardino
Journal:  Abdom Imaging       Date:  1994 Jul-Aug

7.  Interstitial photodynamic therapy in a rat liver metastasis model.

Authors:  R van Hillegersberg; J P Marijnissen; W J Kort; P E Zondervan; O T Terpstra; W M Star
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.